Godrej Agrovet Limited has appointed Sivaram Yadavalli as interim chief executive officer of its Crop Care business, effective November 25, 2026. The leadership change follows the resignation of Rajavelu N.K., who cited an external opportunity as the reason for his departure.

The Board of Directors noted the appointment and cessation on September 21, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Rajavelu’s last working day will be November 24, 2026.

Leadership Transition Details

Sivaram Yadavalli currently serves as Head of Strategy and Business Development at Godrej Agrovet, a position he has held since 2021. His tenure in this role has focused on growth strategy, mergers and acquisitions, business transformation, and new business incubation.

Yadavalli’s background includes management consulting roles at Accenture, Strategy& (PwC), A.T. Kearney, and Tata Strategic Management Group. He holds a gold medal in Business Management from XLRI, Jamshedpur, and a gold medal in Engineering from College of Engineering, Guindy.

The company stated that Yadavalli’s terms of appointment align with its Nomination and Remuneration Policy. The transition aims to ensure continuity in the Crop Care segment’s strategic direction during the interim period.

Godrej Agrovet Limited has scheduled a series of one-on-one meetings with analysts and investors. The interactions are set to take place between September 8 and September 18, 2026.

The company disclosed the schedule under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Management will present information consistent with materials available on the company’s and exchange websites.

Meeting Schedule

The six scheduled sessions allow for both physical attendance and video conference participation. The timings vary across the dates.

Administrative Details

Vivek Raizada, Head – Legal & Company Secretary & Compliance Officer, issued the intimation on September 1, 2026. The company noted that the schedule is subject to change due to exigencies on the part of investors, analysts, or the company.